PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability

Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients

(2010) K. Brockow et al.   ALLERGY

Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice

(2010) Ana Olivera et al.   JOURNAL OF CLINICAL INVESTIGATION

Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis

(2009) Christian Baumgartner et al.   AMERICAN JOURNAL OF PATHOLOGY

STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease

(2009) G. Li et al.   BLOOD

Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs

(2009) K. J. Aichberger et al.   BLOOD

Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade

(2008) N. Harir et al.   BLOOD

Kit- and FcɛRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells

(2007) Shoko Iwaki et al.   CELLULAR SIGNALLING